logo
welcome
Guardian

Guardian

‘Gamechanger’ HIV prevention drug to be made available cheaply in 120 countries

Guardian
Summary
Nutrition label

79% Informative

Gilead Sciences has signed agreements with six manufacturers to make and sell generic lenacapavir in 120 “high-incidence, resource-limited” countries.

But campaigners said the deal “abandons’ many countries with a high HIV burden, particularly in Latin America , and urged transparency over exact pricing.

The drug, given as a twice-yearly injection, has shown strong results for HIV prevention.

VR Score

81

Informative language

83

Neutral language

14

Article tone

formal

Language

English

Language complexity

63

Offensive language

possibly offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

2

Affiliate links

no affiliate links